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ABSTRACT
In this work we evaluate the ability of PLS in generaliz-
ing to unseen clinical cohorts when applied to the analysis
of the joint variation between genotype and phenotype in
Alzheimer’s disease (AD). The model is trained on single-
nucleotide polymorphisms (SNPs) and brain volumes ob-
tained from the ADNI database for a large cohort of healthy
individuals and AD patients, and validated on the ADNI MCI
and ENIGMA cohorts. The experimental results confirm the
ability of PLS in providing a meaningful description of the
joint dynamics between brain atrophy and genotype data in
AD, while providing important generalization results when
tested on clinically heterogeneous cohorts.
Index Terms— GWA, imaging-genetics, genotype, phe-
notype, Alzheimer’s disease, machine learning
1. INTRODUCTION
Imaging genetics is a central scientific field for the discovery
of the mechanisms linking genotype to the phenotypical traits
observable in neuroimaging [1]. Classical genome-wide asso-
ciation (GWA) studies are usually performed by investigating
the relationship between multiple genetic variants and candi-
date phenotypical traits (such as brain regional volumes) by
means of independent univariate analysis [2]. These studies
typically require very large samples in order to detect mean-
ingful associations, since genetic traits usually account for a
small fraction of the phenotype variance. Moreover, since
mass univariate testing does not account for potential gene-
gene interactions, it is highly prone to multiple comparison
problems, and might lead to underpowered discoveries of sig-
nificant associations.
Recent methodological advances in imaging genetics
introduce multivariate approaches to capture meaningful
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genotype-phenotype interactions [3]. Although based on
different statistical assumptions, most of these approaches
rely on simultaneous regression and dimensionality reduction
strategies, such as partial least squares (PLS) [4], or inde-
pendent component analysis (ICA) [5]. In particular, PLS is
an appealing approach due to the parsimonious description
of the multivariate correlation patterns, and for the relative
simplicity of the implementation [6]. Multivariate models
applied to the large dimensional genotype data easily run
into overfitting problems, and the generalization of the re-
lated findings to unseen data is usually problematic. Even
though different cross-validation and regularization strategies
have been introduced in order to mitigate this crucial issue,
it still remains to be verified whether the findings obtained
with high-dimensional multivariate models do generalize to
unseen and heterogeneous clinical cohorts.
In this work we evaluate the ability of PLS in general-
izing to unseen clinical cohorts when applied to the analy-
sis of the joint variation between genotype and phenotype
in Alzheimer’s disease (AD). The analysis proposed in this
work is based on the identification of the meaningful features
associated to the largest PLS weights estimated in a cohort
of AD and healhty individuals (Section 2), and subsequently
validated i) on an ADNI group of subjects affected by mild
cognitive impairment (MCI) (Section 5.2.1), and ii) on the
ENIGMA cohort [7] composed by very heterogeneous clini-
cal populations (Section 5.2.2). The experimental results con-
firm the ability of PLS in providing a meaningful description
of the joint dynamics between brain atrophy and genotype
data in AD, while providing important generalization results.
2. OVERVIEW OF PARTIAL LEAST SQUARES
Let (xi)Ni=1 and (yj)
M
j=1 be distinct sets of features, and let
X and Y be respectively the N × K, and M × K matrices
of (normalized) samples for K distinct subjects. PLS mod-
els the relationship between (xi) and (yj) by finding a latent
space for which the projections of X and Y have maximal
covariance. In practice, PLS can be implemented through the
singular value decomposition (SVD) of the cross-product ma-
Training Data Testing Data
Healthy AD MCIs MCIc
# individuals 409 248 460 228
Sex (% females) 48 56 39 38
MMSE 29.09 ± 1.1 23.22 ± 2 28.02 ± 1.7 26.95 ± 1.8
Education (years) 16.37 ± 2.7 15.33 ± 2.9 16 ± 2.8 15.7 ± 2.8
APOE4 (% 0,1,2) 72, 26, 2 31, 48, 21 56, 35, 9 33, 51, 16
Table 1. Summary socio-demographic, clinical and genetic
information. MCIs: stable MCI subjects, MCIc: MCI sub-
jects converted to AD during the observational time of the
study. MMSE: mini-mental state examination.
trix C = XYT = UΛVT . The columns of the orthogonal
matrices U and V are the eigen-components which character-
ize the common variation of X and Y respectively, and can
be used to explore the modes of joint variability between the
sets of features, while the diagonal matrix Λ is composed by
the eigen-values which quantify the amount of common vari-
ability explained by each component. Finally, for any test ob-
servations (x,y), the projections Px = xTU and Py = yTV
are a low-dimensional representation of the data on the latent
PLS space.
2.1. Efficient Estimation of PLS on high dimensional data
When the dimension of the feature space is large, such as
when analyzing genotype data, the naive storage and analysis
of the associated correlation matrix is usually computation-
ally prohibitive. Fortunately, as illustrated in [8], the SVD
computation of the large matrix C = UΛV can be derived
from the eigen-problem associated to the transposed matrices:
(XTXYTY)A = AL, (1)
and by subsequently computing U = X(YTYBL−
1
2 ), and
V = YB, with B = A
(
ATYTYA
)− 12 , and Λ = L 12 .
3. DATA
We selected genotype and phenotype data available in the
ADNI1/2 datasets for 409 healhty individuals, 248 patients
affected by AD, 460 patients affected by mild cognitive
impairment (MCI), and 228 MCI patients subsequently con-
verted to AD during the observational time of the study.
Summary socio-demographic, clinical and genetic informa-
tion are available in Table 1.
The phenotype features consist in the individual’s re-
gional volumes reported in ADNI1/2 for whole brain, ven-
tricles, and average bilateral hippocampi, enthorinal cortex
and mid-temporal lobes. The volumes were normalized by
covarying for age, total intracranial volume, and sex, and
subsequently standardized by group-wise mean and standard
deviation of the healthy and AD individuals.
The genotype features consist in the individual’s minor al-
lele counts for each of the 1,167,126 single-nucleotide poly-
morphisms (SNPs) in chromosomes 1 to 22 available in the
study. SNP data was downloaded from the ADNI website
and preprocessed with plink [9] by filtering SNPs which did
not meet the quality control criteria (Minor Allele Frequency
(MAF) < 0.01, Genotype Call Rate < 95%, Hardy-Weinberg
Equilibrium < 1x10− 6). Finally, the genotyped SNPs pass-
ing QC were imputed to the HapMap III reference panel and
further QCed to keep only high quality imputed SNPs (i.e.
MAF > 0.01 and RSQR > 0.3), and the missing individual
SNPs were replaced by the group-wise median. The resulting
allele counts were finally standardized by group-wise mean
and standard deviation of the healthy and AD individuals.
Fig. 1. Main PLS eigen-component of V for the phenotype
features. Component 1: ventricles volume is anti-correlated
with respect to the volume of the other brain areas. Compo-
nent 2: hippocampal volume is anti-correlated with respect to
the other brain structures.
4. STATISTICAL ANALYSIS
PLS was applied in order to model the joint variation between
phenotype and genotype observed in healthy and AD individ-
uals. We denote by X the matrix of dimension 1, 167, 130 ×
657 of genotype features for the selected groups, and by Y the
associated phenotype matrix of dimension 5× 657. PLS was
performed by following Section 2.1 in order to identify the
eigen-components U and V of common genotype-phenotype
variation modelled in C = XYT .
The generalization of the PLS model was tested on the
ADNI MCI data by statistically assessing the ability of the
estimated PLS components in providing clinically relevant
separation between MCI subjects converted to AD and sub-
jects that remain stable during the observation period, through
group-wise comparison of the projections in the latent space
spanned by U and V. We also statistically assessed the
group-wise differences between AD and healthy controls
with respect to the set of most informative SNPs associated to
the eigen-component U. The resulting reduced set of SNPs
leading to significant differences was finally tested on the
ADNI MCI and ENIGMA cohort.
5. RESULTS
5.1. Model training and estimated components
The first eigen-components of variation between genotype
and phenotype modelled by PLS in AD and healthy individ-
uals are illustrated in Figures 1 and 2. The analysis of the
respective eigen-values showed that these components alone
accounted for 60% of the total variation in the data (40% for
component 1, and 20% for component 2).
The first component of phenotype variation is identi-
fied by the anti-correlation between ventricles volume and
the volume of the other brain areas (Figure 1). Figure 2
shows the SNPs with largest absolute weights in the geno-
type eigen-components, grouped by chromosome location
(for each eigen-component we identified 584 SNPs above the
99.95th percentile of the distribution of the absolute weights).
The figure reports the percentage of informative SNPs per
chromosome identified by the PLS model with respect to
the number of SNPs available for each chromosome. We
note that chromosome 19 is the most represented among the
SNPs identified by eigen-component 1. The second compo-
nent is characterized by anticorrelation between hippocampal
volume and the other brain structures (principally ventricles
and entorhinal cortex), while the largest represented chromo-
somes are the number 7, 15, and 14. The subsequent linkage
disequilibrium (LD) analysis identified 210 and 232 indepen-
dent SNPs for respectively component 1 and 2, uniformly
distributed across the 22 chromosomes. The significance of
the estimted PLS model was assessed trough permutation test
[10]: the eigenvalues estimated by the model (i.e. the total
explained variability) were higher than the ones obtained by
randomly permuting the rows of the phenotype matrix Y with
1− p = 0.0208 (10e3 permutations).
5.2. Model validation
5.2.1. Generalization to unseen MCI data
Figure 3 shows the differences between stable and converting
MCI subjects in the projection on the latent space spanned
by the first PLS eigen-components. The projection in the la-
tent space leads to significant group-wise differences (Mann
Whitney non-parametric U-test for difference in the median)
for both genotype (p = 0.042, U = 47467, effect size = 0.45,
with a value of 0.5 indicative of no effect) and phenotype
(p < 1e− 4, U = 33397, effect size = 0.31) features.
The group-wise projections with respect to the second
eigen-components were close to significance for the genotype
component (p = 0.087), and significant for the phenotype one
(p < 0.001) (not shown).
5.2.2. Investigation of individual SNPs
Each of the 584 informative SNPs identified by the first PLS
eigen-component was independently tested in order to iden-
Fig. 2. Chromosome representativeness among the set of
most informative SNPs associated to the main PLS eigen-
component of U. Chromosome 19 is the most represented
among the SNPs identified by the first component.
tify group-wise differences between the clinical groups con-
sidered in the study. Table 2 shows the SNPs leading to the
largest statistical evidence for the difference between healthy
and AD individuals (p < 0.05, Bonferroni correction). The
identified SNPs are highly ranked by the PLS model and have
been already reported in previous GWAS studies in AD [11,
12]. The table also reports the statistical significance of the
differences between ADNI MCI stables and converters with
respect to the three identified SNPs. Finally, the last column
reports the statistical association between the identified SNPs
and the hippocampal volume in the ENIGMA cohort [7]. The
identified SNPs consistently lead to significant statistical as-
Fig. 3. The projection in the latent space of the first PLS com-
ponent leads to significant differences between converting and
stable MCIs for both phenotype and genotype features.
SNP PLS ranking (comp. 1,2) Chromosome Gene healthy vs AD MCIs vs MCIc ENIGMA
out of 1,167,126 SNPs
rs157580 36th, - 19 TOMM40 1.2e-7 0.034 0.046
rs2075650 1st, 74th 19 TOMM40 1.3e-14 2.17e-6 0.007
rs157582 9th, - 19 TOMM40 5.4e-13 1.3e-8 0.01
Table 2. Identified SNPs with largest statistical evidence. Column 2: SNPs ranking relative to the absolute weights of the PLS
eigen-components. Comlumns 5-7: p-value for the group-wise comparison (Mann Whitney non-parametric U-test), or for the
correlation with respect to the hippocampal volume in the ENIGMA dataset.
sociation when tested on the clinically heterogeneous MCI
ADNI and ENIGMA cohorts.
6. CONCLUSIONS
PLS provides a valuable alternative to classical univariate
analysis of GWA datasets for studying correlation patterns in
large multidimensional genetic and structural data, by i) pro-
viding meaningful description of the joint dynamics between
brain atrophy and genotype data in AD and, ii) generaliz-
ing to unseen clinically heterogeneous cohorts, such as the
ENIGMA one. In this work the PLS model was trained on
657 ADNI subjects, which represent a tiny fraction (∼ 5%)
of the whole ENIGMA discovery cohort of 13,000 individ-
uals. Although we don’t expect a meaningful impact of the
ADNI subset on the reported generalization of the PLS model
in the ENIGMA cohort (last column of Table 2), we cannot
exclude that this issue might be a potential source of bias of
the resulting statistical result.
Importantly, PLS overcomes the classical multiple com-
parison problem of GWA studies by modeling the joint
correlation of SNPs and brain features through the eigen-
components. We note that this work is based on a standard
implementation of PLS, as opposed to previously proposed
sparse implementations based on the L1 regularization of the
feature weights [4]. However, the posterior analysis pro-
posed in this work focuses on the investigation of the features
associated to the top 0.05% PLS weights with respect to the
L1 norm. The proposed approach is thus based on a heuris-
tic penalization of the PLS components, aimed to promote
stability and sensitivity of the associated findings.
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